How skin cancer cells evade immune system: study

Jan 18, 2011 by Marlowe Hood

Scientists have pinpointed a molecular mechanism in mice which helps skin cancer cells confound the animal's immune system, according to a study released Wednesday.

The discovery -- if duplicated in humans -- could one day lead to drug treatments that block this mechanism, and thus the cancer's growth, the study reported.

In experiments on mice, researchers showed for the first time that a protein called interferon-gamma (IFN-gamma) plays a key role in the spread of melanoma, a notoriously aggressive form of resistant to standard chemotherapy.

The same kind of that leads to sunburn caused white blood cells to infiltrate the skin of the mice, explained Glenn Merlino, a scientist at the US National Cancer Institute and the main architect of the study.

The white blood cells, in turn, "can produce IFN-gamma. We believe that IFN-gamma can promote melanoma in our model system, and perhaps in people," he said in an email.

Injecting the mice with antibodies that block IFN-gamma interrupted this signalling process, effectively reducing the risk of UV-induced , the researchers found.

"We are trying to develop inhibitors that are more practical than antibodies, a small molecule, for example," Merlino said.

Ideally, such a treatment would mean that someone exposed to large doses of -- long summers at the beach without protective cream, for example -- could escape the potentially lethal threat of skin cancer.

"But we would never encourage intense sunbathing, even if such a treatment were available," Merlino cautioned.

Cases of cutaneous malignant melanoma are increasing faster than any other type of cancer.

In 2000, over 200,000 cases of melanoma were diagnosed and there were 65,000 melanoma-associated deaths, according to the World Health Organisation (WHO).

The findings, reported in the British-based science journal Nature, could upend assumptions about the relationship between interferon proteins and cancer, the study suggested.

Up to now, interferons were thought to impede the formation of cancer tumours. One in particular, interferon-alpha, has been widely used to treat , both as a first-line drug and an adjutant.

Earlier research has raised doubts as to effectiveness of the treatment, which also has serious side effects.

The highest recorded incidence was in Australia, where the annual rates are 10 and over 20 times the rates in Europe for women and men respectively.

The main risk factors are high exposure to the sun and other UV sources such as sunbeds, along with genetic factors.

The disease is far more common among people with a pale complexion, blue eyes, and red or fair hair.

Explore further: Team finds new genetic anomalies in lung cancer

add to favorites email to friend print save as pdf

Related Stories

Stem cells could halt osteoporosis, promote bone growth

Mar 04, 2009

While interferon gamma sounds like an outer space weapon, it's actually a hormone produced by our own bodies, and it holds great promise to repair bones affected by osteoporosis. In a new study published in the journal Stem Ce ...

Recommended for you

Bone loss drugs may help prevent endometrial cancer

10 hours ago

A new analysis suggests that women who use bisphosphonates—medications commonly used to treat osteoporosis and other bone conditions—have about half the risk of developing endometrial cancer as women who do not use the ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

fixer
not rated yet Jan 18, 2011
And does Glenn Merlino know that mice and humans have significantly different immune systems and that using mice to develop immune therapies for humans is usually just a waste of mice?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.